Mega CapHealthcareDividend

ABC — Cencora, Inc.

Healthcare Distributors · Founded 2001 · Conshohocken, Pennsylvania · CEO: Steven Collis

Cencora (formerly AmerisourceBergen, rebranded in 2023) is one of the three dominant U.S. pharmaceutical distributors, ranking alongside McKesson and Cardinal Health. The company distributes specialty and traditional pharmaceuticals to community pharmacies, health systems, and physician offices. Cencora has a particularly strong position in specialty drug distribution through its AmerisourceBergen Drug Corporation and World Courier specialty logistics operations. Strategic partnerships with Walgreens Boots Alliance give Cencora significant volume and distribution advantage.

How Cencora, Inc. Makes Money

Drug distribution fees and product spread on branded and generic pharmaceutical wholesale distribution

Specialty distribution of oncology, immunology, and rare disease drugs to physician offices and health systems

World Courier clinical trial and specialty logistics services globally

MWI Animal Health distribution of veterinary pharmaceuticals

Key Metrics Investors Watch

Revenue growth in specialty vs. non-specialty distribution
Adjusted operating income and operating margin
Walgreens Alliance relationship volume and terms
Specialty distribution segment profitability
Free cash flow and capital return to shareholders

Competitive Advantages

Walgreens Boots Alliance strategic partnership provides captive, high-volume distribution relationship
Specialty drug distribution leadership in oncology and immunology is a differentiated, higher-margin capability
World Courier global logistics provides clinical trial supply chain services unavailable from most competitors
Scale and logistics infrastructure provide barriers to new distributor entrants

Key Risks

Walgreens financial difficulties could disrupt the largest customer relationship
Drug pricing reforms targeting the pharmaceutical supply chain could compress distributor spreads
Generic drug price deflation reduces per-unit distribution margins
Opioid settlement obligations remain a legacy liability management issue

Dividend & Capital Return

Cencora pays a quarterly dividend with a long history of growth. The company also conducts share repurchases, returning capital to shareholders consistently.

I Document Every Trade — Even the Losses

Options record: 1W-8L. Net worth: 100% GSE preferred. Get the unfiltered updates.

Unsubscribe anytime. I respect your inbox more than Congress respects property rights.

Frequently Asked Questions

Why did AmerisourceBergen rebrand to Cencora?

AmerisourceBergen rebranded to Cencora in 2023 to better reflect its evolution from a U.S.-focused drug distributor to a global pharmaceutical solutions company with growing international presence and specialty capabilities. This is educational content, not financial advice.

What is Cencora's relationship with Walgreens?

Walgreens Boots Alliance is Cencora's largest customer and also owns a significant equity stake in the company. This strategic partnership gives Cencora a large, predictable volume of prescription drug distribution business through Walgreens' thousands of pharmacies. This is educational content, not financial advice.

Does Cencora pay a dividend?

Yes, Cencora pays a quarterly dividend with a consistent history of increases. Like other distributors, the company is also an active share repurchaser. This is educational content, not financial advice.

What is World Courier?

World Courier is Cencora's specialty logistics subsidiary focused on clinical trial supply chains and temperature-controlled pharmaceutical logistics. It serves biopharmaceutical companies conducting global clinical trials by ensuring precise, compliant sample and drug transport. This is educational content, not financial advice.

How does Cencora compare to McKesson?

Both are among the top three U.S. drug distributors with similar scale and business models. Cencora has stronger specialty distribution capabilities and the Walgreens strategic relationship. McKesson has the US Oncology Network practice management business. Both are mega-cap companies with thin margins and large capital return programs. This is educational content, not financial advice.

Related Stocks

UNH

UnitedHealth Group Incorporated

Healthcare

UnitedHealth Group is the largest health insurance company in the US, serving tens of millions of members through UnitedHealthcare. The company also operates Optum, a diversified health services platform spanning pharmacy benefits, care delivery, and health technology.

CVS

CVS Health Corporation

Healthcare

CVS Health is a vertically integrated healthcare company operating pharmacy benefit management (Caremark), retail pharmacies (9,000+ stores), health insurance (Aetna), and clinic-based care (MinuteClinic, Oak Street Health). The 2018 acquisition of Aetna for $69 billion transformed CVS from a pharmacy chain into a healthcare ecosystem player. CVS manages prescription drug benefits for tens of millions of Americans through Caremark and continues to expand primary care through Oak Street Health, acquired in 2023.

MCK

McKesson Corporation

Healthcare

McKesson is one of the three dominant U.S. pharmaceutical distributors alongside AmerisourceBergen (Cencora) and Cardinal Health, distributing branded and generic drugs, medical supplies, and specialty pharmaceuticals to pharmacies, hospitals, and clinics. As a distributor, McKesson's margins are thin but volumes are enormous. The company also operates oncology specialty distribution and has a growing presence in oncology practice management through The US Oncology Network.

CAH

Cardinal Health, Inc.

Healthcare

Cardinal Health is one of the three dominant U.S. pharmaceutical distributors and a major medical products company. Its pharmaceutical distribution segment provides drug logistics to health systems, retail pharmacies, and mail-order pharmacies. Its GMPD (Global Medical Products and Distribution) segment manufactures and distributes surgical supplies, exam gloves, and medical-surgical products. Cardinal Health spun off its specialty pharmaceutical distributor Specialty Networks and has been restructuring its medical products business to improve profitability.

Recommended Resources

Tools & books I actually use and recommend

SeekingAlpha Premium

Quant ratings, earnings transcripts, and the stock analysis community where I published 300+ articles.

Try SeekingAlpha

The Intelligent Investor

Ben Graham's timeless guide to value investing. The book Warren Buffett calls "the best investing book ever written."

View on Amazon

Interactive Brokers

Low commissions, global market access, and professional-grade tools. This is where I hold my positions.

Open an Account

Some links above are affiliate links. I only recommend products I personally use. See my full disclosures.

Keep Exploring

Hub

All Stocks

Browse all 134 stock profiles by sector.

Best Stocks For Beginners

Curated stock picks for new investors by goal.

Financial Glossary

Understand the terms investors use every day.

Stock vs ETF

Individual stocks vs ETFs — which is right for you?

ETF Profiles

Deep dives on 90+ ETFs across every category.

Buying Your First Stock

How to open a brokerage and buy your first share.

Browse All 134 Stock Profiles

Company information is based on publicly available disclosures and widely-known business facts. No specific price, earnings, or real-time market data is included. This is educational content — not investment advice.